<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31842166</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Age and Lymph Node Positivity in Patients With Colon and Rectal Cancer in the US Military Health System.</ArticleTitle><Pagination><StartPage>346</StartPage><EndPage>356</EndPage><MedlinePgn>346-356</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000001555</ELocationID><Abstract><AbstractText Label="BACKGROUND">Young age may be associated with an increased risk of lymph node involvement at diagnosis of colorectal cancer. Accessibility to care, which is related to cancer detection, tumor stage, and therefore lymph node positivity, may vary by age and thus influence research results.</AbstractText><AbstractText Label="OBJECTIVE">The purpose of this study was to investigate whether young patients had an increased risk of lymph node-positive colon and rectal cancers in the Department of Defense Military Health System, which provides universal health care to its beneficiaries.</AbstractText><AbstractText Label="DESIGN">This was a retrospective, cross-sectional study.</AbstractText><AbstractText Label="SETTINGS">Patients were identified from the US Department of Defense Automated Central Tumor Registry.</AbstractText><AbstractText Label="PATIENTS">Included patients were diagnosed with histologically confirmed primary stage I to III colon and rectal adenocarcinomas between 1989 and 2013, had surgery and &#x2265;1 lymph node examined, and did not receive preoperative radiotherapy. Logistic regression was used to examine the relationships between age at diagnosis (18-49, 50-59, 60-69, and &#x2265;70 y) and lymph node positivity overall and stratified by tumor T stage and number of lymph nodes examined.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">Lymph node positivity of colon and rectal cancers was measured.</AbstractText><AbstractText Label="RESULTS">The youngest patients (aged 18-49 y) were more likely to have lymph node-positive colon and rectal cancers compared with those who were aged &#x2265;70 years after adjustment for potential confounders (OR = 2.04 and 95% CI, 1.63-2.56 for colon cancer; OR = 1.73 and 95% CI, 1.11-2.70 for rectal cancer). A similar tendency was shown in most colon and rectal cancer subgroups stratified by tumor T stage and number of lymph nodes examined.</AbstractText><AbstractText Label="LIMITATIONS">This study was limited by its small sample size for certain subgroup analyses. No information on comorbidities, BMI, or other indicators of health status was available.</AbstractText><AbstractText Label="CONCLUSIONS">In a universal healthcare system, young age was associated with increased lymph node positivity of colon and rectal cancers, suggesting that factors other than access to care may play a role in this association. See Video Abstract at http://links.lww.com/DCR/B90. EDAD Y POSITIVIDAD DE GANGLIOS LINF&#xc1;TICOS EN PACIENTES CON C&#xc1;NCER DEL COLON Y EL RECTO EN EL SISTEMA DE SALUD MILITAR DE EE UU: La edad temprana puede estar asociada con un mayor riesgo de compromiso de los ganglios linf&#xe1;ticos en el momento del diagn&#xf3;stico de c&#xe1;ncer colorrectal. La accesibilidad a la atenci&#xf3;n medica, que est&#xe1; relacionada con la detecci&#xf3;n del c&#xe1;ncer, el estadio del tumor y, por lo tanto, la positividad de los ganglios linf&#xe1;ticos, puede variar seg&#xfa;n la edad y, por lo tanto, influir en los resultados de la investigaci&#xf3;n.Investigar si los pacientes j&#xf3;venes ten&#xed;an un mayor riesgo de c&#xe1;ncer del colon y el recto con ganglios linf&#xe1;ticos positivos en el Sistema de Salud Militar del Departamento de Defensa, que brinda atenci&#xf3;n m&#xe9;dica universal a sus beneficiarios.Estudio transversal retrospectivo.Se identificaron pacientes del Registro Autom&#xe1;tico Central de Tumores del Departamento de Defensa de los Estados Unidos.Fueron diagnosticados con adenocarcinomas del colon y el recto en estadio I-III confirmados histol&#xf3;gicamente entre 1989-2013, se les realiz&#xf3; una cirug&#xed;a y se examinaron &#x2265; 1 ganglio linf&#xe1;tico, y no recibieron radioterapia preoperatoria. La regresi&#xf3;n log&#xed;stica se utiliz&#xf3; para examinar las relaciones entre la edad al momento del diagn&#xf3;stico (18-49, 50-59, 60-69 y &#x2265;70 a&#xf1;os) y la positividad de los ganglios linf&#xe1;ticos en general y fue estratificada por el estadio T tumoral y el n&#xfa;mero de ganglios linf&#xe1;ticos examinados.Positividad de ganglios linf&#xe1;ticos de c&#xe1;ncer del colon y el recto.Los pacientes m&#xe1;s j&#xf3;venes (18-49 a&#xf1;os) ten&#xed;an m&#xe1;s probabilidades de tener c&#xe1;ncer del colon y el recto con ganglios linf&#xe1;ticos positivos en comparaci&#xf3;n con aquellos que ten&#xed;an 70 a&#xf1;os o m&#xe1;s despu&#xe9;s del ajuste por posibles factores de confusi&#xf3;n (odds ratio: 2.04, intervalo de confianza del 95%: 1.63 -2.56 para el c&#xe1;ncer de colon; odds ratio: 1.73, intervalo de confianza del 95%: 1.11-2.70 para el c&#xe1;ncer de recto). Se mostr&#xf3; una tendencia similar en la mayor&#xed;a de los subgrupos de c&#xe1;ncer del colon y el recto estratificados por el estadio T tumoral y el n&#xfa;mero de ganglios linf&#xe1;ticos examinados.Tama&#xf1;o de muestra peque&#xf1;o para ciertos an&#xe1;lisis de subgrupos. No hay informaci&#xf3;n sobre comorbilidades, &#xed;ndice de masa corporal u otros indicadores del estado de salud.En un sistema de salud universal, la edad joven se asoci&#xf3; con un aumento de la positividad de los ganglios linf&#xe1;ticos del c&#xe1;ncer del colon y el recto, lo que sugiere que otros factores adem&#xe1;s del acceso a la atenci&#xf3;n medica pueden desempe&#xf1;ar un papel en esta asociaci&#xf3;n. Consulte Video Resumen en http://links.lww.com/DCR/B90.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alexander</LastName><ForeName>Melannie S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>John P. Murtha Cancer Center Research Program, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, Maryland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>John P. Murtha Cancer Center Research Program, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, Maryland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shriver</LastName><ForeName>Craig D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>John P. Murtha Cancer Center Research Program, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, Maryland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGlynn</LastName><ForeName>Katherine A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Kangmin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>John P. Murtha Cancer Center Research Program, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, Maryland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Z01 CP010158</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003110" MajorTopicYN="N">Colonic Neoplasms</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008207" MajorTopicYN="Y">Lymphatic Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008889" MajorTopicYN="Y">Military Personnel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012004" MajorTopicYN="N">Rectal Neoplasms</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="ANTECEDENTES:">La edad temprana puede estar asociada con un mayor riesgo de compromiso de los ganglios linf&#xe1;ticos en el momento del diagn&#xf3;stico de c&#xe1;ncer colorrectal. La accesibilidad a la atenci&#xf3;n medica, que est&#xe1; relacionada con la detecci&#xf3;n del c&#xe1;ncer, el estadio del tumor y, por lo tanto, la positividad de los ganglios linf&#xe1;ticos, puede variar seg&#xfa;n la edad y, por lo tanto, influir en los resultados de la investigaci&#xf3;n.</AbstractText><AbstractText Label="OBJETIVO:">Investigar si los pacientes j&#xf3;venes ten&#xed;an un mayor riesgo de c&#xe1;ncer del colon y el recto con ganglios linf&#xe1;ticos positivos en el Sistema de Salud Militar del Departamento de Defensa, que brinda atenci&#xf3;n m&#xe9;dica universal a sus beneficiarios.</AbstractText><AbstractText Label="DISE&#xd1;O:">Estudio transversal retrospectivo.</AbstractText><AbstractText Label="MARCO:">Se identificaron pacientes del Registro Autom&#xe1;tico Central de Tumores del Departamento de Defensa de los Estados Unidos.</AbstractText><AbstractText Label="PACIENTES:">Fueron diagnosticados con adenocarcinomas del colon y el recto en estadio I-III confirmados histol&#xf3;gicamente entre 1989&#x2013;2013, se les realiz&#xf3; una cirug&#xed;a y se examinaron &#x2265; 1 ganglio linf&#xe1;tico, y no recibieron radioterapia preoperatoria. La regresi&#xf3;n log&#xed;stica se utiliz&#xf3; para examinar las relaciones entre la edad al momento del diagn&#xf3;stico (18&#x2013;49, 50&#x2013;59, 60&#x2013;69 y &#x2265;70 a&#xf1;os) y la positividad de los ganglios linf&#xe1;ticos en general y fue estratificada por el estadio T tumoral y el n&#xfa;mero de ganglios linf&#xe1;ticos examinados. Resultados Principales Medidos: Positividad de ganglios linf&#xe1;ticos de c&#xe1;ncer del colon y el recto.</AbstractText><AbstractText Label="RESULTADOS:">Los pacientes m&#xe1;s j&#xf3;venes (18&#x2013;49 a&#xf1;os) ten&#xed;an m&#xe1;s probabilidades de tener c&#xe1;ncer del colon y el recto con ganglios linf&#xe1;ticos positivos en comparaci&#xf3;n con aquellos que ten&#xed;an 70 a&#xf1;os o m&#xe1;s despu&#xe9;s del ajuste por posibles factores de confusi&#xf3;n (odds ratio: 2.04, intervalo de confianza del 95%: 1.63 &#x2212;2.56 para el c&#xe1;ncer de colon; odds ratio: 1.73, intervalo de confianza del 95%: 1.11&#x2013;2.70 para el c&#xe1;ncer de recto). Se mostr&#xf3; una tendencia similar en la mayor&#xed;a de los subgrupos de c&#xe1;ncer del colon y el recto estratificados por el estadio T tumoral y el n&#xfa;mero de ganglios linf&#xe1;ticos examinados.</AbstractText><AbstractText Label="LIMITACIONES:">Tama&#xf1;o de muestra peque&#xf1;o para ciertos an&#xe1;lisis de subgrupos. No hay informaci&#xf3;n sobre comorbilidades, &#xed;ndice de masa corporal u otros indicadores del estado de salud.</AbstractText><AbstractText Label="CONCLUSIONES:">En un sistema de salud universal, la edad joven se asoci&#xf3; con un aumento de la positividad de los ganglios linf&#xe1;ticos del c&#xe1;ncer del colon y el recto, lo que sugiere que otros factores adem&#xe1;s del acceso a la atenci&#xf3;n medica pueden desempe&#xf1;ar un papel en esta asociaci&#xf3;n. Vea el video del resumen en http://links.lww.com/DCR/Axxx.</AbstractText></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31842166</ArticleId><ArticleId IdType="mid">NIHMS1549759</ArticleId><ArticleId IdType="pmc">PMC7021218</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000001555</ArticleId><ArticleId IdType="pii">00003453-202003000-00013</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">29313949</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67:177&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pubmed">28248415</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong ML, Schofield JB. Assessment of lymph node involvement in colorectal cancer. World J Gastrointest Surg. 2016;8:179&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4807319</ArticleId><ArticleId IdType="pubmed">27022445</ArticleId></ArticleIdList></Reference><Reference><Citation>Dedavid e Silva TL, Damin DC. Lymph node ratio predicts tumor recurrence in stage III colon cancer. Rev Col Bras Cir. 2013;40:463&#x2013;470.</Citation><ArticleIdList><ArticleId IdType="pubmed">24573624</ArticleId></ArticleIdList></Reference><Reference><Citation>Mroczkowski P, Schmidt U, Sahm M, Gastinger I, Lippert H, Kube R. Prognostic factors assessed for 15,096 patients with colon cancer in stages I and II. World J Surg. 2012;36:1693&#x2013;1698.</Citation><ArticleIdList><ArticleId IdType="pubmed">22411087</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Hollenbeak CS, Stewart DB. Node yield and node involvement in young colon cancer patients: is there a difference in cancer survival based on age? J Gastrointest Surg. 2010;14:1355&#x2013;1361.</Citation><ArticleIdList><ArticleId IdType="pubmed">20585992</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan H, Olszewski AJ, Somasundar P. Lymph node involvement in colon cancer patients decreases with age; a population based analysis. Eur J Surg Oncol. 2014;40:1474&#x2013;1480.</Citation><ArticleIdList><ArticleId IdType="pubmed">25027280</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan X, Chen W, Jiang Z, et al. Exploration of the optimal minimum lymph node count after colon cancer resection for patients aged 80 years and older. Sci Rep. 2016;6:38901.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5150780</ArticleId><ArticleId IdType="pubmed">27941906</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer JE, Cohen SJ, Ruth KJ, Sigurdson ER, Hall MJ. Young age increases risk of lymph node positivity in early-stage rectal cancer. J Natl Cancer Inst. 2016;108:djv284.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4715232</ArticleId><ArticleId IdType="pubmed">26719881</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers EA, Feingold DL, Forde KA, Arnell T, Jang JH, Whelan RL. Colorectal cancer in patients under 50 years of age: a retrospective analysis of two institutions&#x2019; experience. World J Gastroenterol. 2013;19:5651&#x2013;5657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3769901</ArticleId><ArticleId IdType="pubmed">24039357</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo SA, Chew MH, Koh PK, Tang CL. Young colorectal carcinoma patients do not have a poorer prognosis: a comparative review of 2,426 cases. Tech Coloproctol. 2013;17:653&#x2013;661.</Citation><ArticleIdList><ArticleId IdType="pubmed">23460362</ArticleId></ArticleIdList></Reference><Reference><Citation>Wedding U, R&#xf6;hrig B, Klippstein A, Pientka L, H&#xf6;ffken K. Age, severe comorbidity and functional impairment independently contribute to poor survival in cancer patients. J Cancer Res Clin Oncol. 2007;133:945&#x2013;950.</Citation><ArticleIdList><ArticleId IdType="pubmed">17534661</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahnen DJ, Wade SW, Jones WF, et al. The increasing incidence of young-onset colorectal cancer: a call to action. Mayo Clin Proc. 2014;89:216&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pubmed">24393412</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang JM, Chen MC, Changchien CR, et al. Favorable influence of age on tumor characteristics of sporadic colorectal adenocarcinoma: patients 30 years of age or younger may be a distinct patient group. Dis Colon Rectum. 2003;46:904&#x2013;910.</Citation><ArticleIdList><ArticleId IdType="pubmed">12847364</ArticleId></ArticleIdList></Reference><Reference><Citation>Buecher B, Cacheux W, Rouleau E, Dieumegard B, Mitry E, Li&#xe8;vre A. Role of microsatellite instability in the management of colorectal cancers. Dig Liver Dis. 2013;45:441&#x2013;449.</Citation><ArticleIdList><ArticleId IdType="pubmed">23195666</ArticleId></ArticleIdList></Reference><Reference><Citation>Stigliano V, Sanchez-Mete L, Martayan A, Anti M. Early-onset colorectal cancer: a sporadic or inherited disease? World J Gastroenterol. 2014;20:12420&#x2013;12430.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4168075</ArticleId><ArticleId IdType="pubmed">25253942</ArticleId></ArticleIdList></Reference><Reference><Citation>Kneuertz PJ, Chang GJ, Hu CY, et al. Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains. JAMA Surg. 2015;150:402&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pubmed">25806815</ArticleId></ArticleIdList></Reference><Reference><Citation>You YN, Xing Y, Feig BW, Chang GJ, Cormier JN. Young-onset colorectal cancer: is it time to pay attention? Arch Intern Med. 2012;172:287&#x2013;289.</Citation><ArticleIdList><ArticleId IdType="pubmed">22157065</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Li JY, Zhao AL, Gu J. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas. Oncology. 2007;73:52&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">18334831</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong TS, Clark JW, Haigis KM. Cancers of the colon and rectum: identical or fraternal twins? Cancer Discov. 2012;2:117&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pubmed">22585856</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Wei XZ, Fu CG, Zhao RH, Cao FA. Patterns of lymph node metastasis are different in colon and rectal carcinomas. World J Gastroenterol. 2010;16:5375&#x2013;5379.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2980689</ArticleId><ArticleId IdType="pubmed">21072903</ArticleId></ArticleIdList></Reference><Reference><Citation>McFadden C, McKinley B, Greenwell B, et al. Differential lymph node retrieval in rectal cancer: associated factors and effect on survival. J Gastrointest Oncol. 2013;4:158&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3635191</ArticleId><ArticleId IdType="pubmed">23730511</ArticleId></ArticleIdList></Reference><Reference><Citation>Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA. Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst. 2005;97:219&#x2013;225.</Citation><ArticleIdList><ArticleId IdType="pubmed">15687365</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsons HM, Begun JW, Kuntz KM, Tuttle TM, McGovern PM, Virnig BA. Lymph node evaluation for colon cancer in an era of quality guidelines: who improves? J Oncol Pract. 2013;9:e164&#x2013;e171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3710184</ArticleId><ArticleId IdType="pubmed">23942934</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson H, Petrelli N, Carlin A, et al.; National Cancer Institute Expert Panel. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst. 2001;93:583&#x2013;596.</Citation><ArticleIdList><ArticleId IdType="pubmed">11309435</ArticleId></ArticleIdList></Reference><Reference><Citation>American Joint Committee on Cancer. AJCC Cancer Staging Manual. 6th ed. New York: Springer, 2002.</Citation></Reference><Reference><Citation>SEER Progrm Coding and Staging Manual
2015. 
Available at: https://seer.cancer.gov/archive/manuals/2015/AppendixC/colon/surgery_codes.pdf; Accessed
February 11, 2019.</Citation></Reference><Reference><Citation>Parsons HM, Tuttle TM, Kuntz KM, Begun JW, McGovern PM, Virnig BA. Association between lymph node evaluation for colon cancer and node positivity over the past 20 years. JAMA. 2011;306:1089&#x2013;1097.</Citation><ArticleIdList><ArticleId IdType="pubmed">21917579</ArticleId></ArticleIdList></Reference><Reference><Citation>SEER Program Coding and Staging Manual. 2015. 
Available at: https://seer.cancer.gov/archive/manuals/2015/AppendixC/rectum/surgery_codes.pdf; Accessed
February 11, 2019.</Citation></Reference><Reference><Citation>Firth D. Bias reduction of maximum likelihood estimates. Biometrika. 1993;80:27&#x2013;38.</Citation></Reference><Reference><Citation>U.S. Preventive Services Task Force. (2017) Final Recommendation Statement: Colorectal Cancer: Screening. Available at: https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/colorectal-cancer-screening2;
Accessed
July 10, 2017.</Citation></Reference><Reference><Citation>Levin B, Murphy GP. Revision in American Cancer Society recommendations for the early detection of colorectal cancer. CA Cancer J Clin. 1992;42:296&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">1515968</ArticleId></ArticleIdList></Reference><Reference><Citation>Saraste D, Martling A, Nilsson PJ, Blom J, T&#xf6;rnberg S, Janson M. Screening vs. non-screening detected colorectal cancer: differences in pre-therapeutic work up and treatment. J Med Screen. 2017;24:69&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">27470598</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelsattar ZM, Wong SL, Regenbogen SE, Jomaa DM, Hardiman KM, Hendren S. Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening. Cancer. 2016;122:929&#x2013;934.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4777631</ArticleId><ArticleId IdType="pubmed">26808454</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>